Healthcare Global Enterprises Limited Share Price & Analysis
Price Chart
Fundamentals
Concerns
- ✗Premium to sector peers (P/E 341x vs industry 54.4x)
- ✗High premium to book value (P/B 9.6x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
HCG · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 71.29% | 71.28% | 71.26% | 71.23% | 71.22% | 71.22% |
| FII | 6.37% | 6.74% | 3.95% | 4.30% | 2.77% | 2.44% |
| DII | 8.46% | 8.52% | 10.89% | 11.64% | 12.94% | 12.48% |
| Public | 13.89% | 13.45% | 13.90% | 12.84% | 13.07% | 13.86% |
Corporate Events
Rights 1:17 @ Premium Rs 502/-
Latest News
All news →P&G Hygiene & Health Care sees management change
*P&G Hygiene & Health Care reports change in senior management.* The company disclosed a management reshuffle via an NSE filing, without specifying roles or individuals. Such changes may influence strategic direction over time but no immediate financial impact is expected. Investor sentiment likely to remain stable. 📊 *STOCKS:* PGHH | 🏢 *SECTOR:* FMCG | #LOWIMPACT #ManagementChange
Aster DM Healthcare sets record date post-NCLT approval
*Aster DM Healthcare sets record date post-NCLT approval*. The company has noted the NCLT order and fixed a record date for the amalgamation scheme. The move paves the way for the proposed corporate restructuring. Shareholders will be eligible for benefits based on the record date. 📊 *STOCKS:* ASTERDM | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Amalgamation
Aster DM Healthcare to acquire healthcare assets
*Aster DM Healthcare to acquire healthcare assets.* The company announced a strategic acquisition to expand its medical network. Deal size and specific assets remain undisclosed. This move aims to strengthen its presence in key markets. 📊 *STOCKS:* ASTERDM | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Acquisition
P&G Hygiene and Health Care announces management change
*P&G Hygiene and Health Care announces management change* — The company has disclosed a change in its senior management personnel to the stock exchange. No further details on the individuals involved or the nature of the change were provided. Such corporate updates typically have limited market impact unless tied to strategic shifts. 📊 *STOCKS:* PGHH | 🏢 *SECTOR:* FMCG | #LOWIMPACT #ManagementChange
Aster DM Healthcare completes merger with Quality Care India
*Aster DM Healthcare completes merger with Quality Care India* Aster DM Healthcare announced the successful completion of its merger with Quality Care India Limited, effective July 02, 2026. The consolidation aims to strengthen Aster’s hospital network and enhance operational scale. This integration is expected to improve cost efficiencies and expand patient reach across key markets. 📊 *STOCKS:* ASTERDM | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Merger
P&G to hold 62nd AGM on September 2, 2026
*P&G to hold 62nd AGM on September 2, 2026.* The company has informed the exchange about the upcoming annual general meeting. No financial updates or strategic announcements were disclosed. This is a routine corporate calendar update. 📊 *STOCKS:* PGHH | 🏢 *SECTOR:* FMCG | #LOWIMPACT #AGM
GPT Healthcare shares may react to newspaper publication
*GPT Healthcare shares may react to newspaper publication* as the company filed a copy of its newspaper publication with the NSE. This appears to be a routine disclosure with no **₹ value** or financial impact indicated. No specific event like dividend, merger, or result is mentioned. Traders should monitor for further clarity. 📊 *STOCKS:* GPTHEALTH | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CorporateFiling
P&G Hygiene discloses insider trading regulation filing
*P&G Hygiene discloses insider trading regulation filing.* The company filed disclosure under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015. This is a routine regulatory requirement and does not indicate any adverse action. No financial impact is expected from this disclosure. 📊 *STOCKS:* PGHH | 🏢 *SECTOR:* FMCG | #LOWIMPACT #InsiderTrading
P&G India to present investor update
*P&G India to present investor update.* The company informed the exchange about an upcoming investor presentation. This event aims to provide updates on business strategy and performance. No financial figures or major announcements were disclosed. 📊 *STOCKS:* PGHH | 🏢 *SECTOR:* FMCG | #LOWIMPACT #investor-presentation
Healthcare Global Enterprises publishes newspaper notice
*Healthcare Global Enterprises publishes newspaper notice.* This is a routine corporate filing submitted to the NSE. No financial or operational details were disclosed. Such notices are typically procedural. 📊 *STOCKS:* HGEL | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #corporate
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹652.33 Cr ▲3.0% | ₹633.07 Cr ▼2.1% | ₹646.85 Cr ▲5.5% | ₹613.16 Cr ▲4.8% | ₹585.16 Cr ▲4.8% | ₹558.57 Cr ▲0.9% | ₹553.54 Cr ▲5.3% | ₹525.58 Cr |
| Op. Profit | ₹125.08 Cr ▲14.2% | ₹109.56 Cr ▼11.2% | ₹123.31 Cr ▲14.4% | ₹107.79 Cr ▲2.0% | ₹105.63 Cr ▲19.5% | ₹88.38 Cr ▼13.6% | ₹102.24 Cr ▲12.5% | ₹90.9 Cr |
| OPM | 19.2% ▲10.7% | 17.3% ▼9.2% | 19.1% ▲8.4% | 17.6% ▼2.6% | 18.1% ▲14.1% | 15.8% ▼14.3% | 18.5% ▲6.8% | 17.3% |
| Net Profit | ₹4.04 Cr ▲151.1% | ₹-7.9 Cr ▼138.2% | ₹20.66 Cr ▲245.5% | ₹5.98 Cr ▼11.7% | ₹6.77 Cr ▼12.6% | ₹7.75 Cr ▼62.5% | ₹20.68 Cr ▲51.7% | ₹13.63 Cr |
| EPS (₹) | 0.15 ▲123.8% | -0.63 ▼157.8% | 1.09 ▲240.6% | 0.32 ▼36.0% | 0.5 ▲6.4% | 0.47 ▼61.5% | 1.22 ▲48.8% | 0.82 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2.5K Cr ▲14.7% | ₹2.2K Cr ▲16.2% | ₹1.9K Cr ▲12.8% | ₹1.7K Cr ▲21.2% | ₹1.4K Cr ▲38.3% | ₹1.0K Cr ▼7.6% | ₹1.1K Cr ▲11.9% | ₹976 Cr ▲17.7% | ₹829 Cr ▲18.4% | ₹700 Cr |
| Expenses | ₹2.1K Cr ▲13.4% | ₹1.8K Cr ▲16.1% | ₹1.6K Cr ▲13.4% | ₹1.4K Cr ▲20.1% | ₹1.2K Cr ▲30.9% | ₹887 Cr ▼5.2% | ₹936 Cr ▲8.3% | ₹864 Cr ▲21.2% | ₹713 Cr ▲19.8% | ₹595 Cr |
| Op. Profit | ₹466 Cr ▲21.4% | ₹384 Cr ▲17.4% | ₹327 Cr ▲10.1% | ₹297 Cr ▲26.9% | ₹234 Cr ▲91.8% | ₹122 Cr ▼22.3% | ₹157 Cr ▲40.2% | ₹112 Cr ▼3.4% | ₹116 Cr ▲10.5% | ₹105 Cr |
| OPM | 18.0% ▲5.9% | 17.0% ▲0.0% | 17.0% ▼5.6% | 18.0% ▲5.9% | 17.0% ▲41.7% | 12.0% ▼14.3% | 14.0% ▲27.3% | 11.0% ▼21.4% | 14.0% ▼6.7% | 15.0% |
| Other Income | ₹-18 Cr ▼146.2% | ₹39 Cr ▲62.5% | ₹24 Cr ▲60.0% | ₹15 Cr ▼86.4% | ₹110 Cr ▲252.8% | ₹-72 Cr ▼820.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▼60.0% | ₹25 Cr ▲150.0% | ₹10 Cr |
| Interest | ₹177 Cr ▲14.2% | ₹155 Cr ▲42.2% | ₹109 Cr ▲4.8% | ₹104 Cr ▲6.1% | ₹98 Cr ▼17.6% | ₹119 Cr ▼13.8% | ₹138 Cr ▲97.1% | ₹70 Cr ▲66.7% | ₹42 Cr ▲82.6% | ₹23 Cr |
| Depreciation | ₹244 Cr ▲15.6% | ₹211 Cr ▲21.3% | ₹174 Cr ▲6.7% | ₹163 Cr ▲3.2% | ₹158 Cr ▼0.6% | ₹159 Cr ▲7.4% | ₹148 Cr ▲74.1% | ₹85 Cr ▲19.7% | ₹71 Cr ▲24.6% | ₹57 Cr |
| PBT | ₹27 Cr ▼52.6% | ₹57 Cr ▼16.2% | ₹68 Cr ▲51.1% | ₹45 Cr ▼48.9% | ₹88 Cr ▲138.4% | ₹-229 Cr ▼92.4% | ₹-119 Cr ▼260.6% | ₹-33 Cr ▼222.2% | ₹27 Cr ▼22.9% | ₹35 Cr |
| Tax % | 15.0% ▲7.1% | 14.0% ▼64.1% | 39.0% ▼36.1% | 61.0% ▲8.9% | 56.0% ▲1966.7% | -3.0% ▼160.0% | 5.0% ▲171.4% | -7.0% ▼118.4% | 38.0% ▲11.8% | 34.0% |
| Net Profit | ₹23 Cr ▼53.1% | ₹49 Cr ▲19.5% | ₹41 Cr ▲127.8% | ₹18 Cr ▼53.8% | ₹39 Cr ▲117.6% | ₹-221 Cr ▼76.8% | ₹-125 Cr ▼303.2% | ₹-31 Cr ▼282.4% | ₹17 Cr ▼26.1% | ₹23 Cr |
| EPS (₹) | 0.92 ▼69.4% | 3.01 ▼8.0% | 3.27 ▲64.3% | 1.99 ▼45.5% | 3.65 ▲125.0% | -14.58 ▼28.3% | -11.36 ▼327.1% | -2.66 ▼219.3% | 2.23 ▼8.6% | 2.44 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹149 Cr ▲7.2% | ₹139 Cr ▲0.0% | ₹139 Cr ▲0.0% | ₹139 Cr ▲0.0% | ₹139 Cr ▲11.2% | ₹125 Cr ▲40.4% | ₹89 Cr ▲1.1% | ₹88 Cr ▲1.1% | ₹87 Cr ▲1.2% | ₹86 Cr |
| Reserves | ₹1.2K Cr ▲51.1% | ₹783 Cr ▲14.1% | ₹686 Cr ▼4.9% | ₹721 Cr ▼1.4% | ₹731 Cr ▲27.8% | ₹572 Cr ▲95.2% | ₹293 Cr ▼24.7% | ₹389 Cr ▼9.1% | ₹428 Cr ▲23.3% | ₹347 Cr |
| Borrowings | ₹1.7K Cr ▼5.6% | ₹1.8K Cr ▲44.2% | ₹1.3K Cr ▲41.4% | ₹901 Cr ▼1.5% | ₹915 Cr ▼6.3% | ₹977 Cr ▼27.5% | ₹1.3K Cr ▲104.7% | ₹658 Cr ▲41.8% | ₹464 Cr ▲10.5% | ₹420 Cr |
| Other Liabilities | ₹855 Cr ▲9.6% | ₹780 Cr ▲29.8% | ₹601 Cr ▲9.5% | ₹549 Cr ▲26.8% | ₹433 Cr ▲21.3% | ₹357 Cr ▼31.1% | ₹518 Cr ▲0.6% | ₹515 Cr ▲11.7% | ₹461 Cr ▲23.9% | ₹372 Cr |
| Total Liabilities | ₹3.9K Cr ▲10.8% | ₹3.5K Cr ▲31.1% | ₹2.7K Cr ▲16.9% | ₹2.3K Cr ▲4.2% | ₹2.2K Cr ▲9.2% | ₹2.0K Cr ▼9.6% | ₹2.2K Cr ▲36.1% | ₹1.6K Cr ▲14.6% | ₹1.4K Cr ▲17.6% | ₹1.2K Cr |
| Assets | ||||||||||
| Fixed Assets | ₹2.5K Cr ▲0.8% | ₹2.4K Cr ▲38.9% | ₹1.8K Cr ▲13.2% | ₹1.6K Cr ▲0.4% | ₹1.5K Cr ▲11.9% | ₹1.4K Cr ▼16.0% | ₹1.6K Cr ▲69.7% | ₹970 Cr ▲17.1% | ₹828 Cr ▲20.9% | ₹685 Cr |
| CWIP | ₹19 Cr ▼24.0% | ₹25 Cr ▼69.9% | ₹83 Cr ▲361.1% | ₹18 Cr ▼18.2% | ₹22 Cr ▼26.7% | ₹30 Cr ▼34.8% | ₹46 Cr ▼69.9% | ₹153 Cr ▼12.1% | ₹174 Cr ▲17.6% | ₹148 Cr |
| Investments | ₹14 Cr ▲27.3% | ₹11 Cr ▲10.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲11.1% | ₹9 Cr ▼65.4% | ₹26 Cr ▼23.5% | ₹34 Cr ▼30.6% | ₹49 Cr ▼7.5% | ₹53 Cr ▲381.8% | ₹11 Cr |
| Other Assets | ₹1.4K Cr ▲34.5% | ₹1.1K Cr ▲24.9% | ₹850 Cr ▲16.4% | ₹730 Cr ▲13.9% | ₹641 Cr ▲8.1% | ₹593 Cr ▲14.0% | ₹520 Cr ▲8.8% | ₹478 Cr ▲24.2% | ₹385 Cr ▲1.0% | ₹381 Cr |
| Total Assets | ₹3.9K Cr ▲10.8% | ₹3.5K Cr ▲31.1% | ₹2.7K Cr ▲16.9% | ₹2.3K Cr ▲4.2% | ₹2.2K Cr ▲9.2% | ₹2.0K Cr ▼9.6% | ₹2.2K Cr ▲36.1% | ₹1.6K Cr ▲14.6% | ₹1.4K Cr ▲17.6% | ₹1.2K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹347 Cr ▲9.5% | ₹317 Cr ▲11.2% | ₹285 Cr ▲13.1% | ₹252 Cr ▲14.5% | ₹220 Cr ▲81.8% | ₹121 Cr ▼6.9% | ₹130 Cr ▲32.7% | ₹98 Cr ▲0.0% | ₹98 Cr ▲7.7% | ₹91 Cr |
| Investing CF | ₹-177 Cr ▲63.7% | ₹-488 Cr ▼115.9% | ₹-226 Cr ▼69.9% | ₹-133 Cr ▼206.4% | ₹125 Cr ▲173.1% | ₹-171 Cr ▼69.3% | ₹-101 Cr ▲57.6% | ₹-238 Cr ▲15.9% | ₹-283 Cr ▼34.8% | ₹-210 Cr |
| Financing CF | ₹241 Cr ▲673.8% | ₹-42 Cr ▲34.4% | ₹-64 Cr ▲54.3% | ₹-140 Cr ▲9.7% | ₹-155 Cr ▼238.4% | ₹112 Cr ▲293.1% | ₹-58 Cr ▼169.0% | ₹84 Cr ▼47.8% | ₹161 Cr ▲80.9% | ₹89 Cr |
| Net Cash Flow | ₹410 Cr ▲292.5% | ₹-213 Cr ▼4160.0% | ₹-5 Cr ▲77.3% | ₹-22 Cr ▼111.6% | ₹190 Cr ▲206.5% | ₹62 Cr ▲306.7% | ₹-30 Cr ▲46.4% | ₹-56 Cr ▼133.3% | ₹-24 Cr ▲17.2% | ₹-29 Cr |
| Free Cash Flow | ₹59 Cr ▼46.4% | ₹110 Cr ▲8.9% | ₹101 Cr ▼19.8% | ₹126 Cr ▼16.0% | ₹150 Cr ▲76.5% | ₹85 Cr ▲269.6% | ₹23 Cr ▲125.6% | ₹-90 Cr ▲43.0% | ₹-158 Cr ▼56.4% | ₹-101 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 60d ▼9.1% | 66d ▲17.9% | 56d ▼13.8% | 65d ▲14.0% | 57d ▼14.9% | 67d ▲8.1% | 62d ▲5.1% | 59d ▲3.5% | 57d ▲5.6% | 54d |
| Inventory Days | 32d ▼3.0% | 33d ▲0.0% | 33d ▲0.0% | 33d ▲6.5% | 31d ▼3.1% | 32d ▼8.6% | 35d ▼22.2% | 45d ▼2.2% | 46d ▲15.0% | 40d |
| Days Payable | 185d ▼11.9% | 210d ▼2.8% | 216d ▲0.9% | 214d ▲7.5% | 199d ▼10.0% | 221d ▼5.6% | 234d ▼22.8% | 303d ▲10.6% | 274d ▲0.7% | 272d |
| Cash Conv. Cycle | -93d ▲16.2% | -111d ▲12.6% | -127d ▼9.5% | -116d ▼3.6% | -112d ▲7.4% | -121d ▲11.0% | -136d ▲32.0% | -200d ▼17.0% | -171d ▲3.9% | -178d |
| Working Capital Days | -61d ▲33.0% | -91d ▼30.0% | -70d ▼75.0% | -40d ▲7.0% | -43d ▼65.4% | -26d ▲74.5% | -102d ▲7.3% | -110d ▼48.6% | -74d ▲33.9% | -112d |
| ROCE | 8.0% ▼11.1% | 9.0% ▲0.0% | 9.0% ▲12.5% | 8.0% ▲60.0% | 5.0% ▲600.0% | -1.0% ▼200.0% | 1.0% ▼66.7% | 3.0% ▼50.0% | 6.0% ▼14.3% | 7.0% |
Source: Screener.in · Lower days = better efficiency
About Healthcare Global Enterprises Limited
Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.[1]
Healthcare · Healthcare Services